AMERIPRISE FINANCIAL INC - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 49 filers reported holding ARBUTUS BIOPHARMA CORP in Q1 2016. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q3 2023$198,940
-11.7%
98,0000.0%0.00%
Q2 2023$225,400
-24.9%
98,000
-1.1%
0.00%
Q1 2023$300,273
+38.4%
99,100
+6.6%
0.00%
Q4 2022$217,000
-16.5%
93,000
-31.8%
0.00%
Q3 2022$260,000
-10.3%
136,300
+27.4%
0.00%
Q2 2022$290,000
-10.5%
107,000
-1.8%
0.00%
Q1 2022$324,000
-21.0%
108,907
+3.3%
0.00%
Q4 2021$410,000
+48.0%
105,386
+63.2%
0.00%
Q3 2021$277,000
+39.2%
64,561
-1.6%
0.00%
Q2 2021$199,000
-62.0%
65,621
-58.2%
0.00%
Q1 2021$523,000
-76.9%
157,028
-75.4%
0.00%
-100.0%
Q4 2020$2,262,000
+10.2%
637,292
-2.8%
0.00%0.0%
Q3 2020$2,052,000
+107.9%
655,499
+527.2%
0.00%
Q3 2018$987,000
+1956.2%
104,506
+682.9%
0.00%
Q2 2017$48,000
-73.2%
13,349
-75.7%
0.00%
Q1 2017$179,000
+29.7%
54,958
-2.4%
0.00%
Q4 2016$138,000
-38.7%
56,328
-14.0%
0.00%
Q3 2016$225,000
-3.0%
65,481
-1.8%
0.00%
Q2 2016$232,000
-16.8%
66,677
-1.2%
0.00%
Q1 2016$279,000
-7.9%
67,471
-0.8%
0.00%
Q4 2015$303,000
+74.1%
68,033
+138.4%
0.00%
Q3 2015$174,00028,5410.00%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q1 2016
NameSharesValueWeighting ↓
Two Seas Capital LP 825,569$3,211,0002.46%
GREAT POINT PARTNERS LLC 668,907$2,602,0000.58%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 270,000$1,050,0000.47%
QCM Cayman, Ltd. 10,205$40,0000.24%
Pitti Group Wealth Management, LLC 50,000$195,0000.22%
RTW INVESTMENTS, LP 2,504,493$9,742,0000.14%
Hudson Bay Capital Management LP 1,805,700$7,024,0000.07%
Quinn Opportunity Partners LLC 276,485$1,076,0000.07%
Kepos Capital LP 200,000$778,0000.06%
XTX Topco Ltd 29,026$113,0000.06%
View complete list of ARBUTUS BIOPHARMA CORP shareholders